NTRK1 and cancer: Importantly, at both early and late time points, pHR LV associated with DEG that were implicated in tyrosine kinase receptor signalling pathways and cellular senescence in contrast to pHV LV where DEG associated with p13K and MAPK cancer signalling pathway activation.